⌘K

Login Start Free

Home/Filings/4/0001225208-18-004461

4//SEC Filing

HILL CHARLES H 4

Accession 0001225208-18-004461

CIK 0000078003other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:38 PM ET

Size

10.8 KB

Accession

0001225208-18-004461

Insider Transaction Report

Form 4

Period: 2018-02-24

Executive Vice President

Transactions

Tax Payment
Common Stock
2018-02-24$36.26/sh−17,674$640,859→ 104,935 total
Exercise/Conversion
Common Stock
2018-02-24$18.90/sh+65,280$1,233,792→ 122,609 total
Tax Payment
Common Stock
2018-02-24$35.98/sh−20,829$749,427→ 84,106 total
Exercise/Conversion
Stock Appreciation Rights
2018-02-24−65,280→ 0 total
Exercise: $18.90From: 2018-02-24Exp: 2018-02-24→ Common Stock (65,280 underlying)

Holdings

Common Stock
(indirect: By Rule 16b-3 Plan)
11,417

Footnotes (5)

[F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
[F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
[F3]Price is the closing price of Pfizer common stock on February 23, 2018
[F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
[F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

4
doc4.xmlPrimary

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1

filerCIK 0001508517

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 7:38 PM ET
Size: 10.8 KB

View on SEC.gov